Hubei Goto Biopharm Co.,Ltd. (SHE:300966)
China · Delayed Price · Currency is CNY 21.75
+0.05 (0.23%)
Apr 22, 2026, 12:05 PM CST
Hubei Goto Biopharm Market Cap
Hubei Goto Biopharm has a market cap or net worth of 2.5 billion as of April 21, 2026. Its market cap has increased by 33.23% in one year.
Market Cap
2.50B
Enterprise Value
3.76B
Revenue
626.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
21.75
Market Cap Chart
Since April 9, 2021, Hubei Goto Biopharm's market cap has decreased from 6.57B to 2.50B, a decrease of -61.99%. That is a compound annual growth rate of -17.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 2.50B | 10.21% |
| Dec 31, 2025 | 2.27B | 21.86% |
| Dec 31, 2024 | 1.86B | -29.78% |
| Dec 29, 2023 | 2.65B | -14.93% |
| Dec 30, 2022 | 3.11B | -34.18% |
| Dec 31, 2021 | 4.73B | -28.02% |
| Apr 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guangdong VTR Bio-Tech | 2.99B |
| Suzhou Fushilai Pharmaceutical | 2.87B |
| Shanghai Hile Bio-Technology | 2.81B |
| Shandong Sito Bio-technology | 2.65B |
| Shanghai Universal Biotech | 2.62B |
| Jilin Jian Yisheng Pharmaceutical | 2.49B |
| Sailong Pharmaceutical Group | 2.32B |
| Zhejiang East Asia Pharmaceutical | 2.27B |